Within the newly named Sensofar Group, two distinct divisions covering metrology and medical applications have now been established as part of the company's restructuring process. Sensofar Metrology will be led by Gerald Nitsch and Sensofar Medical is to be headed up by former CEO of the Group Professor Ferran Laguarta.
The changes are designed to secure Sensofar's near and long-term development, both as a new innovator in the medical technology field and as a rapidly growing supplier of cutting-edge 3D optical metrology systems to industry, respectively.
Sensofar Metrology provides continuity for Sensofar-Tech's previous industry and R&D metrology activities. The company's portfolio includes 3D metrology systems for micromanufacturing, semiconductors, palaeontology, consumer electronics, optics, forensics and material quality control, bespoke R&D systems for diverse high-resolution profilometry tasks as well as OEM metrology engines for leading systems suppliers.
Nitsch is tasked with ensuring a healthy operational transition during this continued period of rapid growth for the company. At the same time he retains his position as VP sales and marketing for the Sensofar Group.
As CEO of Sensofar Medical, Laguarta will oversee the recently announced Q six system that has been designed as a dedicated solution for simplifying and streamlining stent assessment and approval. Laguarta, a major stockholder and co-founder, remains on the board at Sensofar and will continue to be involved in current and future projects and growth strategies of the Group as a whole.